[1] 潘文冰,陆瑶,李岩,等. 基于循证医学的叙事护理模式对原发性肝癌患者经导管动脉化疗栓塞术后早期离床活动和依从性的影响[J]. 肝癌电子杂志,2023,10(3):89-92. [2] Xu W, Zhu Z, Yu J, et al. Symptoms experienced after transcatheter arterial chemoembolization in patients with primary liver cancer: a network analysis[J]. Asia Pac J Oncol Nurs, 2024, 11(3): 100361. [3] Yu Y, Fu J, Xia P, et al. A systematic review and meta-analysis on the efficacy and safety of transcatheter arterial chemoembolization combined with radiofrequency ablation in the treatment of primary liver cancer[J]. Transl Cancer Res, 2022, 11(5): 1297-1308. [4] 黄澜,朱宗国,冯涛. 血清甲胎蛋白、PIVKA-Ⅱ、GGT、GGT/ALT检测对早期原发性肝癌的诊断价值[J]. 临床和实验医学杂志,2024,23(7):749-752. [5] Zhang Q, Jiao X.LDH and GGT/ALT ratio as novel prognostic biomarkers in hepatocellular carcinoma patients after liver transplantation[J]. Comput Math Methods Med, 2021, 2021: 9809990. [6] 孟园园,李梦华,梁曦月,等. 甲胎蛋白-系统性免疫炎症指数/白蛋白评分对早期肝癌射频消融术后患者的预后评估价值[J]. 肿瘤基础与临床,2022,35(4):315-320. [7] Yang Y, He X, Tan S, et al. The association between immunoinflammatory biomarkers NLR, PLR, LMR and nonalcoholic fatty liver disease: a systematic review and meta-analysis[J]. Clin Exp Med, 2025, 25(1): 39. [8] 王京艳,王华明,刘妍,等. 血清白细胞介素-6和γ-谷氨酰转移酶联合检测对TACE治疗AFP阴性肝癌患者的疗效与预后评价[J]. 解放军医学杂志,2019,44(5):394-399. [9] Jia Y, Xing Y, Yang M. Efficacy of sorafenib combined with interventional therapy on primary liver cancer patients and its effect on serum AFP, VEGF, and GGT[J]. J Oncol, 2021, 2021: 9120265. [10] 刘通,王万超,陈思吟,等. 丙氨酸氨基转移酶水平对原发性肝癌发病风险的预测价值(附95 780例报告)[J]. 中华消化外科杂志,2020,19(12):1257-1265. [11] Moldogazieva N T, Zavadskiy S P, Sologova S S, et al. Predictive biomarkers for systemic therapy of hepatocellular carcinoma[J]. Expert Rev Mol Diagn, 2021, 21(11): 1147-1164. [12] 武文华,蔡芝芳,李亚萍,等. 肝动脉化疗栓塞联合射频消融治疗原发性肝癌患者血清炎症因子变化及其对远期生存率的影响[J]. 实用肝脏病杂志,2024,27(6):927-930. [13] 梁长华,毛华杰,梁盼,等. 原发性肝癌320排容积CT灌注参数值与肿瘤体积及肝功能Child-Pugh分级的相关性[J]. 新乡医学院学报,2018,35(1):65-68. [14] 欧杰,陈闯,诸佳瑜,等. 175例原发性肝癌中医证型与Child-Pugh分级相关性的研究[J]. 四川中医,2017,35(1):54-57. |